Balancing efficacy and safety in the management of atopic dermatitis: the role of methylprednisolone aceponate. - Wikidata - wikimedia - TriplyDB

Balancing efficacy and safety in the management of atopic dermatitis: the role of methylprednisolone aceponate.

Balancing efficacy and safety in the management of atopic dermatitis: the role of methylprednisolone aceponate.

http://www.wikidata.org/entity/Q37835871

about

Topical tacrolimus for atopic dermatitis Topical tacrolimus for atopic dermatitis In vivo investigations on the penetration of various oils and their influence on the skin barrier.Atopic dermatitis in children: management of pruritus.Frontiers of rapid itch relief: a review of methylprednisolone aceponate.Methylprednisolone aceponate for atopic dermatitis.Fast itch relief in an experimental model for methylprednisolone aceponate topical corticosteroid activity, based on allergic contact eczema to nickel sulphate.Circadian rhythm in atopic dermatitis-Pathophysiology and implications for chronotherapy.

P2860

Q24186624-C25D4B0D-2DDD-430C-A958-592897BA3D0F Q24198110-894F4F5C-9769-4FE9-90AD-0BB229DE2215 Q34076718-32A7BF58-9FD5-40E0-9B0C-C888CAAF7072 Q38052176-96E160EC-9DA5-45F9-B43F-01531AD209F9 Q38052177-8C4ECAEA-F17B-46A7-A1D7-ABBAF732BE39 Q39160898-868568BC-5266-495C-A417-A15B7CA75AEF Q39210471-45890E2E-7CD1-4CA6-8103-78970BA144B6 Q46838494-5AFEA30D-092D-4150-8AB8-433A00CD4898

P2860

Balancing efficacy and safety in the management of atopic dermatitis: the role of methylprednisolone aceponate.

http://www.wikidata.org/entity/Q37835871

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Balancing efficacy and safety ...... methylprednisolone aceponate.

@en

Balancing efficacy and safety ...... methylprednisolone aceponate.

@nl

type

label

Balancing efficacy and safety ...... methylprednisolone aceponate.

@en

Balancing efficacy and safety ...... methylprednisolone aceponate.

@nl

prefLabel

Balancing efficacy and safety ...... methylprednisolone aceponate.

@en

Balancing efficacy and safety ...... methylprednisolone aceponate.

@nl

P1433

Q37835871-F44DC75E-1D57-47D2-AD6C-F01EB65EA1E4

P1476

Q37835871-8184C353-68F9-4302-82FA-A9A32C26AC2F

P2093

Q37835871-0E6D9949-3CB4-4BE3-AE43-8E5AF089BA01

P2860

Q37835871-19A5E55C-94BE-46D4-B9B6-68425DDE2F2E

Q37835871-207E0615-2F41-4A7E-B9D6-424CA8AFE6DF

Q37835871-2EE064FF-E21F-4545-B316-0C83CBCC0EFC

Q37835871-32E57DF1-6A6C-4202-AB4A-278A1BCD29A8

Q37835871-350A3810-7EDB-4F42-A5DC-A311B6F83B8E

Q37835871-45482EB4-A7EE-46C2-A59B-17C1B355478A

Q37835871-4E150A6F-885D-469D-B100-C9025F48C805

Q37835871-60C075BD-F54C-4D65-A868-74625AC9C042

Q37835871-655298C8-A6D1-4F27-AF3B-A97BAFFFA95D

Q37835871-6F1E8FEB-AE74-4C0C-B2C6-7DA21C350406

P304

Q37835871-8BC32D6D-434B-4145-8B1E-F941C376703E

P31

Q37835871-61DEACB1-7AAC-4B35-A366-B6ED345B379D

P356

Q37835871-BEB70B3A-9CB8-44C1-A332-FB98182AA77F

P433

Q37835871-3B253B00-1BC5-4EAD-8FDF-C988B68CDCD2

P478

Q37835871-5844F704-DF4D-41CE-BE9F-B4C76580AA67

P577

Q37835871-2F34C349-4914-416D-B2F7-CD8BE658B802

P698

Q37835871-636ECDE4-8A02-44B2-9BA0-923E1307FCBA

P356

J.1468-3083.2010.03789.X

P1433

Journal of the European Academy of Dermatology and Venereology

P1476

Balancing efficacy and safety ...... methylprednisolone aceponate.

@en

P2093

T A Luger

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy and safety of methylprednisolone aceponate ointment 0.1% compared to tacrolimus 0.03% in children and adolescents with an acute flare of severe atopic dermatitis

Growth in atopic eczema.

An alternate mechanism of glucocorticoid anti-proliferative effect: promotion of a Th2 cytokine-secreting profile.

Glucocorticosteroid inhibition of cytokine production: relevance to antiallergic actions.

Adverse effects of topical glucocorticosteroids.

New and established topical corticosteroids in dermatology: clinical pharmacology and therapeutic use.

Galenics of dermal products--vehicles, properties and drug release.

Bioavailability and bioequivalence of topical glucocorticoids.

An appraisal of the methods used in the assessment of atrophy from topical corticosteroids.

Topical corticosteroids and unwanted local effects. Improving the benefit/risk ratio.

P304

251-258

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1468-3083.2010.03789.X

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21294777

http://www.w3.org/2001/XMLSchema#string